Abstract
A pronounced affinity between melanin and chlorpromazine has been known since the early 1960’s, when Potts [1] in this country and Rutschmann and associates [2] of the Sandoz Laboratories at Basel detected accumulation of phenothiazine derivatives in the melanin-bearing eye tissues of experimental animals. The drug concentration was found to exceed the uniform rate of distribution by a factor of 30 to 50, depending on the phenothiazine compound used. We previously reported on chlorpromazine levels in the autopsied tissues of a chronically dosed patient [3] and found the drug content in hair higher than in any of the visceral, bone, or keratinous tissues examined. In 1964, Greiner and his group [4–6] called attention to late side effects of high and prolonged doses of chlorpromazine, manifested by “melanosis” in a genetically predisposed group of patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Potts, A.M.: Uveal pigment and phenothiazine compounds, Tr. Am. Ophth. Soc. 60:517, 1962.
Rutschmann, J., et al.: Localization of phenothiazine s in the eye, Psychopharmacology Service Center Bulletin 2(5):73, 1962.
Forrest, F.M., et al.: Clinical, biochemical, and post-mortem studies on a patient treated with chlorpromazine, Agressologie 4:259, 1963.
Greiner, A.C., and Berry, K.: Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy, Can. Med. Assoc. J. 90:363, 1964.
Greiner, A.C., and Nicolson, G. A.: Pigment deposition in viscera associated with prolonged chlorpromazine therapy. Can. Med. Assoc. J. 91:627, 1964.
Greiner, A.C., et al.: Therapy of chlorpromazine melanosis. Can. Med. Assoc. J. 91:636, 1964.
Piattelli, M., and Nicolaus, R. A.: The Structure of melanins and melanogenesis: I, Tetrahedron 15:66, 1961
Nicolaus, R. A.: Biogenesis of melanins, Rass. Med. Sper. 9 (Suppl. 1): 1, 1962.
Bolt, A.G.: Interactions between human melanoprotein and chlorpromazine derivatives. I. Isolation and purification of human melanoprotein from hair and melanoma tissue, Life Sci. 6:1277, 1967.
Forrest, I.S., et al.: In vitro interaction of chlorpromazine and melanin, Agressologie 7:147, 1966.
Bolt, A.G., and Forrest, I.S.: Interactions between human melanoprotein and chlorpromazine derivatives. II. Spectrophotometric studies, Life Sci. 6:1285, 1967.
Greiner, A.C., and Nicolson, G.A.: Schizophrenia-melanosis—cause or side effect?, Lancet (7423):1165, 1965.
Bolt, A.G., and Forrest, I.S.: 7-Hydroxychlorpromazine in normal and abnormal human chlorpromazine metabolism, Proc. Western Pharmacol. Soc. 10:11, 1967.
Zelickson, A.S.: Skin changes and chlorpromazine, J. Am. Med. Assoc. 198:341, 1966.
Perry, T.L., et al.: 7-Hydroxychlorpromazine: Potential toxic drug metabolite in psychiatric patients, Science 146:81, 1964.
Forrest, I.S., et al.: Studies on chlorpromazine metabolites in mammalian tissues, Abstract No. 546, Fed. Proc. 26(2):353, 1967.
Fishman, V., and Goldenberg, H.: Metabolism of chlorpromazine IV. Identification of 7-hydroxychlorpromazine and its sulfoxide and desmethyl derivatives, Proc. Soc. Exptl. Biol. Med. 112:501, 1963.
Beckett, A.H., et al.: Metabolism of chlorpromazine in humans, Biochem. Pharmacol. 12:779, 1963.
Bolt, A.G., et al.: Quantitative studies of urinary excretion of chlorpromazine metabolites in chronically dosed psychiatric patients, J. Pharm. Sci. 55:1205, 1966
Bolt, A. G., and Forrest, I.S.: Assay of chlorpromazine glucuronides in human urine, J. Pharm. Sci. 56:1533, 1967.
Forrest, F.M., et al.: Incidence of late “melanosis” side effects in chronic mental patients after long term phenothiazine therapy, Proc. Western Pharmacol. Soc. 9:18, 1966.
Gunby, B. et al.: Late oculocutaneous complications in phenothiazine therapy, Acta Pyschiat. Scand. 41:97, 1965.
Gombos, G.M., and Yarden, P.E.: Ocular and cutaneous side effects after prolonged chlorpromazine treatment, Am. J. Psychiat. 123:872, 1967.
Forrest, I.S., and Bolt, A.G.: Inter-species differences in chlorpromazine metabolism, Proc. Western Pharmacol. Soc. 10:30, 1967.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1968 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bolt, A.G., Forrest, I.S. (1968). In Vivo and In Vitro Interactions of Chlorpromazine and Melanin. In: Wortis, J. (eds) Recent Advances in Biological Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9072-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9072-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-9074-9
Online ISBN: 978-1-4684-9072-5
eBook Packages: Springer Book Archive